Response Biomedical (V.RBM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Response Biomedical (V.RBM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Christopher Millard who started this subject	4/25/2002 2:36:30 AM
From: Dick Martin	Read Replies (1) of 655

The company resources are now directed toward bringing the cardiac markers (Troponin I and CK-MB )to market. Clinical trials are planned to start this summer and submission to the FDA in the Fall followed by marketing in early 2003. The Anthrax test is in the final stages of the first commercial sales, but there is no further development of other bio-warfare tests. The prostate test is still in development by the Japanese partner, we are waiting for news. There seems to strong investor interest and an investment fund wanting in. Things are developing very quickly right now and there must be a lot going on under the surface. I am holding, this should be a great year; I don't want to miss. Regards -Dick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next